Literature DB >> 18396795

Factors influencing EPA+DHA levels in red blood cells in Japan.

Miho Itomura1, Shuntaro Fujioka, Kei Hamazaki, Kouji Kobayashi, Tetsuro Nagasawa, Shigeki Sawazaki, Yuko Kirihara, Tomohito Hamazaki.   

Abstract

The blood eicosapentaenoic and docosahexaenoic acid (EPA+DHA) concentration is an important inverse risk factor for sudden cardiac death. However, it is not known what kinds of factors influence the EPA+DHA levels in the total phospholipid fraction in red blood cells (RBC EPA+DHA) in Japan, who regularly eat more fish with increasing age. Four hundred and fifty-six healthy individuals (320 men and 136 women, 18 to 70 years old) were recruited between 2002 and 2005. RBC EPA+DHA were measured by gas chromatography and questionnaires were administered. Multivariate analysis indicated that there were significant correlations between RBC EPA+DHA and (i) dietary EPA+DHA (beta=0.31), (ii) age (beta=0.33), (iii) gender (beta=-0.15) and (iv) physical activity (beta=-0.11) but not with body mass index or smoking.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18396795

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  44 in total

1.  Clinical correlates and heritability of erythrocyte eicosapentaenoic and docosahexaenoic acid content in the Framingham Heart Study.

Authors:  William S Harris; James V Pottala; Sean M Lacey; Ramachandran S Vasan; Martin G Larson; Sander J Robins
Journal:  Atherosclerosis       Date:  2012-06-07       Impact factor: 5.162

2.  The Effects of Dietary Omega-3s on Muscle Composition and Quality in Older Adults.

Authors:  Gordon I Smith
Journal:  Curr Nutr Rep       Date:  2016-04-02

Review 3.  Preventative strategies for early-onset bipolar disorder: towards a clinical staging model.

Authors:  Robert K McNamara; Jayasree J Nandagopal; Stephen M Strakowski; Melissa P DelBello
Journal:  CNS Drugs       Date:  2010-12       Impact factor: 5.749

4.  Substudies of the Japan EPA Lipid Intervention Study (JELIS).

Authors:  William S Harris
Journal:  Curr Atheroscler Rep       Date:  2009-11       Impact factor: 5.113

5.  Omega-3 index levels and associated factors in a middle-aged French population: the MONA LISA-NUT Study.

Authors:  A Wagner; C Simon; B Morio; J Dallongeville; J B Ruidavets; B Haas; B Laillet; D Cottel; J Ferrières; D Arveiler
Journal:  Eur J Clin Nutr       Date:  2014-10-22       Impact factor: 4.016

6.  n-3 PUFAs improve erythrocyte fatty acid profile in patients with small AAA: a randomized controlled trial.

Authors:  Lara T Meital; Mark T Windsor; Rebecca M L Ramirez Jewell; Peter Young; Karl Schulze; Rebecca Magee; Jill O'Donnell; Pankaj Jha; Maria Perissiou; Jonathan Golledge; Tom G Bailey; Peter Brooks; Christopher D Askew; Fraser D Russell
Journal:  J Lipid Res       Date:  2019-03-26       Impact factor: 5.922

7.  Higher serum EPA or DHA, and lower ARA compositions with age independent fatty acid intake in Japanese aged 40 to 79.

Authors:  Rei Otsuka; Yuki Kato; Tomoko Imai; Fujiko Ando; Hiroshi Shimokata
Journal:  Lipids       Date:  2013-02-07       Impact factor: 1.880

8.  Detection and Treatment of Long-Chain Omega-3 Fatty Acid Deficiency in Adolescents with SSRI-Resistant Major Depressive Disorder.

Authors:  Robert K McNamara; Jennifer Strimpfel; Ronald Jandacek; Therese Rider; Patrick Tso; Jeffrey A Welge; Jeffrey R Strawn; Melissa P Delbello
Journal:  PharmaNutrition       Date:  2014-04-01

9.  Low docosahexaenoic acid status is associated with reduced indices in cortical integrity in the anterior cingulate of healthy male children: a 1H MRS Study.

Authors:  Robert K McNamara; Ronald Jandacek; Patrick Tso; Wade Weber; Wen-Jang Chu; Stephen M Strakowski; Caleb M Adler; Melissa P Delbello
Journal:  Nutr Neurosci       Date:  2013-07       Impact factor: 4.994

10.  Membrane omega-3 Fatty Acid deficiency as a preventable risk factor for comorbid coronary heart disease in major depressive disorder.

Authors:  Robert K McNamara
Journal:  Cardiovasc Psychiatry Neurol       Date:  2009-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.